Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

AVITA Medical, Inc.

RCEL · Nasdaq; OTC · CIK 0001762303 · Healthcare · Medical Devices

INSIDER SIGNAL

50.8 / 100

2 buyers · 12 purchase transaction lines · $213.5K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+14.0 / 35
Purchase size+10.6 / 25
Role+15.0 / 20
Recency+1.2 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: CFO

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
O'Toole David DCFO
●●○○●
Woody Joseph FralinDirector
●●●●●
Vance Cary GuyPresident and CEO
○
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION88%Largest buyer: Woody Joseph Fralin · $188.6K
CLUSTER BUYING · 15D2 insidersPeak activity: 2026-05-19–2026-06-03

Roles in the peak window: CFO, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

50.8 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 51.0
  2. 51.0
  3. 50.9
  4. 50.9
  5. 50.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

14Purchases
0Sales
5Other Form 4 lines
14SEC filings · 365 days
BUYING12 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER3 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+34.0%
3M
+234.4%
6M
+163.7%
12M
+139.7%

Volatility & liquidity

Volatility
96.9%
Beta
—
Avg daily value
USD 5.9M

Valuation

Market cap
USD 408.5M
P/E
—

Fundamentals

Profit margin
-67.8%
ROE
—
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-03 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,887,981
Previous report
2,885,693
Avg daily volume
313,878
Days to cover
9.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-12O'Toole David DPurchase (P)Common Stock2,000USD 3.97USD 7,940SEC filing ↗
2026-06-09Woody Joseph FralinPurchase (P)Common Stock5,200USD 4.00USD 20,800SEC filing ↗
2026-06-09Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.19USD 41,900SEC filing ↗
2026-06-03Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.09USD 40,950SEC filing ↗
2026-06-02Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.20USD 41,950SEC filing ↗
2026-06-01Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.30USD 43,000SEC filing ↗
2026-05-20O'Toole David DPurchase (P)Common Stock2,000USD 4.26USD 8,520SEC filing ↗
2026-05-19O'Toole David DPurchase (P)Common Stock2,000USD 4.24USD 8,480SEC filing ↗
2026-03-11O'Toole David DPurchase (P)Common Stock1,800USD 4.78USD 8,604SEC filing ↗
2026-02-19O'Toole David DPurchase (P)Common Stock3,000USD 4.15USD 12,450SEC filing ↗
2025-08-28McNamara RobertPurchase (P)Common Stock10,000USD 4.50USD 45,000SEC filing ↗
2025-08-26O'Toole David DPurchase (P)Common Stock2,000USD 4.52USD 9,040SEC filing ↗
2025-08-19McNamara RobertPurchase (P)Common Stock10,000USD 5.00USD 50,000SEC filing ↗
2025-08-12O'Toole David DPurchase (P)Common Stock2,000USD 4.81USD 9,620SEC filing ↗
2025-03-06McNamara RobertPurchase (P)Common Stock11,000USD 8.30USD 91,300SEC filing ↗

Form 4 evidence

19 transaction lines in the latest 365-day window; 127 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-12O'Toole David DPurchase (P)Common Stock2,000USD 3.97USD 7,940SEC filing ↗
2026-06-12O'Toole David DAward / grant (A)Common Stock2,000USD 3.97USD 7,940SEC filing ↗
2026-06-09Woody Joseph FralinPurchase (P)Common Stock5,200USD 4.00USD 20,800SEC filing ↗
Show recent Form 4 evidence (15 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-12O'Toole David DPurchase (P)Common Stock2,000USD 3.97USD 7,940SEC filing ↗
2026-06-12O'Toole David DAward / grant (A)Common Stock2,000USD 3.97USD 7,940SEC filing ↗
2026-06-09Woody Joseph FralinPurchase (P)Common Stock5,200USD 4.00USD 20,800SEC filing ↗
2026-06-09Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.19USD 41,900SEC filing ↗
2026-06-03Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.09USD 40,950SEC filing ↗
2026-06-02Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.20USD 41,950SEC filing ↗
2026-06-01Woody Joseph FralinPurchase (P)Common Stock10,000USD 4.30USD 43,000SEC filing ↗
2026-05-29Vance Cary GuyAward / grant (A)Common Stock5,000USD 3.05USD 15,250SEC filing ↗
2026-05-29O'Toole David DAward / grant (A)Common Stock5,000USD 3.05USD 15,250SEC filing ↗
2026-05-20O'Toole David DPurchase (P)Common Stock2,000USD 4.26USD 8,520SEC filing ↗
2026-05-19O'Toole David DPurchase (P)Common Stock2,000USD 4.24USD 8,480SEC filing ↗
2026-03-11O'Toole David DPurchase (P)Common Stock1,800USD 4.78USD 8,604SEC filing ↗
2026-02-19O'Toole David DPurchase (P)Common Stock3,000USD 4.15USD 12,450SEC filing ↗
2026-02-18O'Toole David DAward / grant (A)Common Stock105,470USD —USD —SEC filing ↗
2026-02-18KELSEY NICOLEAward / grant (A)Common Stock98,390USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRCEL
CIK0001762303
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq; OTC

Data coverage

Local Form 4 history127 transaction lines from 2020-07-16 to 2026-06-12
48 P purchase lines · 13 S sale lines · 66 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.